ArticleFoods (Basel, Switzerland)2026
Preliminary Quality and Safety Evaluation of Lycopene-Based Dietary Supplements: Analysis of Active Compound Content, Microbiological Purity, and Chemical Contaminants.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dietary supplements, especially lycopene-containing ones, are of interest because of their antioxidant and potential health-promoting effects; however, their actual composition and safety have not been sufficiently verified. This study evaluated the accuracy of labelled lycopene content and assessed selected chemical and microbiological safety parameters in commercially available products. Lycopene levels were determined spectrophotometrically and by HPLC, whereas pesticide residues, heavy metals, and microbiological purity were analysed using validated regulatory-compliant methods. Marked inconsistencies were found between the declared and measured lycopene content, with HPLC revealing concentrations up to 70% above label claims. Methomyl (0.059 mg/kg), a pesticide not approved in the EU, was detected in one supplement, heavy metal concentrations met current regulatory limits, and other elements remained below quantification thresholds. Microbiological quality was satisfactory, with low total viable counts and absence of pathogens, yeasts, and moulds; only low levels of environmental spore-forming bacteria were detected. The findings highlight acceptable microbiological and elemental safety but reveal substantial deviations in lycopene content labelled/determined and the presence of a non-approved pesticide (however, below the MRL). A comprehensive multi-parameter quality assessment is essential to ensure the safety, reliability, and regulatory compliance of lycopene supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.